Chen Lu Selected Research

Chen Lu Research Topics

Disease

27	Neoplasms (Cancer) 01/2022 - 02/2007
9	Neoplasm Metastasis (Metastasis) 01/2022 - 09/2011
7	Stomach Neoplasms (Stomach Cancer) 01/2022 - 01/2019
6	Reperfusion Injury 03/2015 - 09/2010
5	Fibrosis (Cirrhosis) 10/2020 - 02/2011
5	Infarction (Infarctions) 03/2015 - 09/2010
4	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2020
4	Glioma (Gliomas) 12/2021 - 02/2007
4	Melanoma (Melanoma, Malignant) 12/2021 - 01/2017
4	Inflammation (Inflammations) 10/2020 - 02/2011
3	Breast Neoplasms (Breast Cancer) 01/2022 - 11/2009
3	Carcinoma (Carcinomatosis) 12/2021 - 05/2011
3	Hepatocellular Carcinoma (Hepatoma) 12/2021 - 10/2020
3	Testicular Neoplasms (Testicular Cancer) 06/2021 - 01/2017
3	Cardiovascular Diseases (Cardiovascular Disease) 04/2021 - 02/2011
3	Infections 04/2019 - 04/2015
3	Hyperplasia 01/2019 - 02/2011
3	IGA Glomerulonephritis (IGA Nephropathy) 12/2018 - 09/2011
3	Brain Ischemia (Cerebral Ischemia) 04/2014 - 12/2010
3	Sepsis (Septicemia) 01/2012 - 03/2010
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2022 - 10/2021
2	Hypersensitivity (Allergy) 01/2022 - 05/2013
2	COVID-19 01/2022 - 04/2021
2	Pancreatic Neoplasms (Pancreatic Cancer) 12/2021 - 01/2020
2	Carcinogenesis 10/2021 - 01/2019
2	Falciparum Malaria (Plasmodium falciparum Malaria) 11/2020 - 04/2019
2	Schistosomiasis (Bilharziasis) 11/2020 - 12/2018
2	Hypoxia (Hypoxemia) 10/2020 - 03/2015
2	Hyperalgesia 10/2020 - 03/2020
2	Myocardial Infarction 01/2020 - 01/2014
2	Genomic Instability 01/2019 - 11/2009
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2019 - 01/2018
2	Wounds and Injuries (Trauma) 12/2018 - 07/2014
2	Obesity 12/2016 - 01/2013
2	Hypertension (High Blood Pressure) 11/2016 - 09/2014
2	Crohn Disease (Crohn's Disease) 01/2016 - 12/2010
2	Myocardial Ischemia (Ischemic Heart Diseases) 10/2015 - 01/2014
2	Prostatic Neoplasms (Prostate Cancer) 06/2012 - 09/2011
2	Stroke (Strokes) 03/2010 - 11/2004
1	Edema (Dropsy) 01/2022
1	Cardiotoxicity 01/2022
1	Hematologic Neoplasms (Hematological Malignancy) 01/2022
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2022
1	Colonic Neoplasms (Colon Cancer) 01/2022

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 06/2021 - 11/2009
7	Circular RNAIBA 01/2022 - 01/2019
6	Messenger RNA (mRNA)IBA 01/2022 - 01/2018
6	Competitive Endogenous RNAIBA 01/2022 - 01/2019
5	LigandsIBA 01/2016 - 03/2010
4	AntigensIBA 01/2022 - 01/2017
4	Pharmaceutical PreparationsIBA 01/2022 - 01/2021
4	Biomarkers (Surrogate Marker)IBA 06/2021 - 05/2012
4	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2020
4	TeaIBA 11/2020 - 12/2018
4	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2018 - 01/2014
3	Long Noncoding RNAIBA 12/2022 - 01/2021
3	Therapeutic UsesIBA 01/2022 - 04/2014
3	evolocumabIBA 10/2021 - 09/2018
3	CytokinesIBA 03/2020 - 01/2016
3	triphenyltetrazoliumIBA 08/2011 - 09/2010
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 06/2018
2	Matrix Metalloproteinases (MMPs)IBA 01/2022 - 01/2018
2	ZincIBA 01/2022 - 12/2021
2	6-methyladenineIBA 12/2021 - 03/2021
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2021 - 05/2020
2	LDL CholesterolIBA 10/2021 - 09/2018
2	UbiquitinIBA 10/2021 - 02/2011
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 06/2021 - 01/2020
2	RNA (Ribonucleic Acid)IBA 03/2021 - 10/2020
2	Hemoglobins (Hemoglobin)IBA 01/2021 - 09/2019
2	Serum AlbuminIBA 01/2021 - 01/2016
2	Amodiaquine (Camoquin)FDA Link 11/2020 - 04/2019
2	ArtesunateIBA 11/2020 - 04/2019
2	EnzymesIBA 03/2020 - 01/2019
2	Small Interfering RNA (siRNA)IBA 01/2020 - 01/2019
2	Neuroprotective AgentsIBA 12/2019 - 01/2014
2	ethyl pyruvateIBA 01/2019 - 01/2018
2	CollagenIBA 01/2019 - 01/2018
2	NF-kappa B (NF-kB)IBA 01/2018 - 05/2006
2	Anti-Bacterial Agents (Antibiotics)IBA 11/2016 - 02/2009
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2016 - 04/2015
2	Vitamin D FDA LinkGeneric 09/2014 - 01/2013
2	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2009 - 02/2007
1	Aromatic HydrocarbonsIBA 01/2022
1	2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amideIBA 01/2022
1	Ticlopidine (Ticlid)FDA LinkGeneric 01/2022
1	AntibodiesIBA 01/2022
1	Rituximab (Mabthera)FDA Link 01/2022
1	Poly(amidoamine)IBA 01/2022
1	AllergensIBA 01/2022
1	Antisense RNA (Anti-Sense RNA)IBA 01/2022
1	FumaratesIBA 01/2022
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2022
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022
1	Chimeric Antigen ReceptorsIBA 01/2022

Therapy/Procedure

6	Therapeutics 01/2022 - 08/2011
4	Immunotherapy 01/2022 - 04/2008
3	Ligation 01/2019 - 03/2010
2	Punctures 01/2012 - 03/2010